Zydus Lifesciences Gets USFDA Approval for Generic Methylene Blue Injection
December 6, 2023 16:56
Zydus Lifesciences has received USFDA approval to market a generic version of ProvayBlue injection, a treatment for acquired methemoglobinemia. The company's vial presentation offers a...